Combined DGAT1 and DGAT2 inhibition provided a synergistic effect that completely reverted the steatosis phenotypes of both genetic and FFA-induced steatosis models, already evident at nanomolar concentrations (Supplementary Fig. 9a–e). Here, DGAT1 is linked to steatosis.